Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanalact Pro Laves
- Development stage
- Unknown
- Lead developer
- Laves-Arzneimittel
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Sanalact Pro Laves is an over-the-counter dietary supplement developed and marketed by Laves-Arzneimittel to support the digestion of milk and dairy products. It is formulated as a fixed-dose combination of two digestive enzymes: lactase (4,500 FCC units, derived from Aspergillus oryzae) and protease (50,000 HUT, derived from Bacillus subtilis). Lactase hydrolyzes lactose into glucose and galactose, while protease facilitates the breakdown of milk proteins such as casein and whey protein. This dual-action formulation is designed to assist individuals with lactose intolerance or sensitivity to milk proteins, with enzymatic activity beginning in the stomach.
- Brand names
- Sanalact Pro Laves
- Other names
- Sanalact Pro
Beyond the preview
Go deeper on Sanalact Pro Laves.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sanalact Pro Laves.